The use of risk estimation models for the induction of secondary cancers following radiotherapy

Acta Oncologica

Volumn 44, Issue 4, 2005, Pages 339-347

  Daşu, Alexandru ^a,b   Toma Daşu, Iuliana ^a   Olofsson, Jörgen ^a   Karlsson, Mikael ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CELL KILLING; CONTROLLED STUDY; GENE MUTATION; HUMAN; METASTASIS; MODEL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; INCIDENCE; LUNG NEOPLASMS; MODELS, THEORETICAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; ORGAN SPECIFICITY; RADIATION TOLERANCE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTAL NEOPLASMS; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 22544463627     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860510029833     Document Type: Article

References (29)

1. Schneider U, Lomax A, Lombriser N. Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation. Radiat Res 2000;154:382-8.
2. Lindsay KA, Wheldon EG, Deehan C, Wheldon TE. Radiation carcinogenesis modelling for risk of treatment-related second tumours following radiotherapy. Br J Radiol 2001;74:529-36.
3. Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002;54:824-9.
4. Gray LH. Radiation biology and cancer. In: Cellular radiation biology: A symposium considering radiation effects in the cell and possible implications for cancer therapy. Baltimore: The Williams and Wilkins Company; 1965. p. 7-25.
5. Upton AC. Radiobiological effects of low doses. Implications for radiological protection. Radiat Res 1977;71:51-74.
6. Mole RH. Dose-response relationships. In: Boice JD, Fraumeni Jr. JF, eds. Radiation carcinogenesis: epidemiology and biological significance. New York: Raven Press; 1984. p 403-20.
7. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83-8.
8. Hall EJ, Henry S. Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationships for carcinogenesis. Int J Radiat Oncol Biol 2004;80:327-37.
9. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-51.
10. Epstein R, Hanham I, Dale R. Radiotherapy-induced second cancers: are we doing enough to protect young patients? Eur J Cancer 1997;33:526-30.
11. Boice Jr. JD, Day NE, Andersen A, Brinton LA, Brown R, Choi NW, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985;74:955-75.
12. Tucker MA, Jones PH, Boice Jr. JD, Robison LL, Stone BJ, Stovall M, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res 1991;51:2885-8.
13. Inskip PD, Stovall M, Flannery JT. Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1994;86:983-8.
14. Verllen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999;53:199-203.
15. Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000;88:398-406.
16. Dörr W, Herrmann T. Cancer induction by radiotherapy: dose dependence and spatial relationship to irradiated volume. J Radiol Prot 2002;22:A117-21.
17. Loeffler JS, Niemierko A, Chapman PH. Second tumors after radiosurgery: tip of the iceberg or a bump in the road? Neurosurgery 2003;52:1436-40.
18. Mazonakis M, Damilakis J, Varveris H, Fasoulaki M, Gourtsoyiannis N. Risk estimation of radiation-induced thyroid cancer from treatment of brain tumors in adults and children. Int J Oncol 2003;22:221-5.
19. Schneider U. Dose-response relationship for radiation-induced cancer-decrease or plateau at high dose: in regard to Davis (Int J Radiat Oncol Biol Phys 2004;59:916). Int J Radiat Oncol Biol Phys 2005;61:312-3.
20. UNSCEAR. Sources and Effects of Ionising Radiation 1993 Report to the General Assembly, with annexes. New York: United Nations; 1993.
21. ICRP. ICRP Publication 60: 1990 Recommendations of the International Commission on Radiological Protection. Annals of the ICRP 1991;21:1-202.
22. Thames HD, Hendry JH. Fractionation in radiotherapy. London-New York-Philadelphia: Taylor & Francis; 1987.
23. Brenner DJ. Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 2004;60:1013-5.
24. Zaider M, Zelefsky MJ, Cohen GN, Chui CS, Yorke ED, Ben Porat L, et al. Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2005;61:702-13.
25. Kellerer AM. Risk estimates for radiation-induced cancer-the epidemiological evidence. Radiat Environ Biophys 2000;39:17-24.
26. Hall EJ. Radiobiology for the radiologist, 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2000.
27. Tucker JD, Sorensen KJ, Chu CS, Nelson DO, Ramsey MJ, Urlando C, et al. The accumulation of chromosome aberrations and Dlb-1 mutations in mice with highly fractionated exposure to gamma radiation. Mutat Res 1998;400:321-35.
28. Rao BS, Natarajan AT. Retrospective biological dosimetry of absorbed radiation. Radiat Prot Dosimetry 2001;95:17-23.
29. Shimono K, Shikazono N, Inoue M, Tanaka A, Watanabe H. Effect of fractionated exposure to carbon ions on the frequency of chromosome aberrations in tobacco root cells. Radiat Environ Biophys 2001;40:221-5.